Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$82.2M |
| 2 |
Conagra Brands
CAG
|
+$63.5M |
| 3 |
Intuit
INTU
|
+$53.2M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$51.9M |
| 5 |
CVS Health
CVS
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$40.5M |
| 2 |
Merck
MRK
|
+$39.5M |
| 3 |
DD
Du Pont De Nemours E I
DD
|
+$38.8M |
| 4 |
Viatris
VTRS
|
+$38.8M |
| 5 |
DaVita
DVA
|
+$37.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Industrials | 19.34% |
| 3 | Healthcare | 18.39% |
| 4 | Consumer Discretionary | 16.87% |
| 5 | Consumer Staples | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Mondelez International
MDLZ
$82.3B
| $10.2M | 0.12% |
224,365
-114,925
| -34% | -$5.01M |
|
277
Pilgrim's Pride
PPC
$7.68B
| $10.2M | 0.12% |
400,206
+175,681
| +78% | +$4.41M |
|
|
FPRX
278
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $9.98M | 0.12% |
241,475
+128,508
| +114% | +$5.59M |
|
|
AMAG
279
DELISTED
AMAG Pharmaceuticals
AMAG
| $9.85M | 0.12% |
411,912
+207,728
| +102% | +$4.76M |
|
|
CSRA
280
DELISTED
CSRA Inc.
CSRA
| $9.8M | 0.12% |
418,466
+385,406
| +1,166% | +$9.69M |
|
|
SDRL
281
DELISTED
Seadrill Limited Common Stock
SDRL
| $9.74M | 0.12% |
11,223
+3,288
| +41% | +$3.13M |
|
282
G-III Apparel Group
GIII
$1.43B
| $9.71M | 0.12% |
212,368
+199,603
| +1,564% | +$8.61M |
|
|
BKS
283
DELISTED
Barnes & Noble
BKS
| $9.69M | 0.12% |
853,388
+588,923
| +223% | +$6.82M |
|
|
RGC
284
DELISTED
Regal Entertainment Group
RGC
| $9.6M | 0.12% |
435,679
+198,754
| +84% | +$4.12M |
|
285
Universal Corp
UVV
$1.12B
| $9.6M | 0.12% |
166,273
+102,855
| +162% | +$5.67M |
|
|
BWLD
286
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $9.59M | 0.12% |
+69,028
| New | +$9.77M |
|
287
SPX Corp
SPXC
$10.4B
| $9.53M | 0.11% |
641,603
+456,309
| +246% | +$7.24M |
|
288
NetApp
NTAP
$37.7B
| $9.52M | 0.11% |
387,299
-139,712
| -27% | -$3.44M |
|
289
KLA
KLAC
$240B
| $9.44M | 0.11% |
1,289,240
-521,150
| -29% | -$3.74M |
|
|
CVSA
290
Covista Inc
CVSA
$4.51B
| $9.35M | 0.11% |
+524,186
| New | +$9.24M |
|
291
Vertex Pharmaceuticals
VRTX
$139B
| $9.35M | 0.11% |
108,656
+103,610
| +2,053% | +$8.95M |
|
|
MDR
292
DELISTED
McDermott International
MDR
| $9.34M | 0.11% |
630,109
+245,284
| +64% | +$3.31M |
|
293
Buckle
BKE
$2.26B
| $9.31M | 0.11% |
358,405
+95,687
| +36% | +$2.58M |
|
|
TIF
294
DELISTED
Tiffany & Co.
TIF
| $9.24M | 0.11% |
152,451
-105,535
| -41% | -$7.01M |
|
295
Greif
GEF
$5B
| $9.04M | 0.11% |
242,486
+221,974
| +1,082% | +$7.95M |
|
296
Benchmark Electronics
BHE
$2.61B
| $9.03M | 0.11% |
426,786
+27,491
| +7% | +$574K |
|
297
Service Corp International
SCI
$11.4B
| $9.02M | 0.11% |
333,584
+91,651
| +38% | +$2.42M |
|
298
CSX Corp
CSX
$95.6B
| $8.96M | 0.11% |
1,031,055
+981,369
| +1,975% | +$8.55M |
|
299
Gentex
GNTX
$4.98B
| $8.95M | 0.11% |
+579,318
| New | +$9.2M |
|
300
JetBlue
JBLU
$1.85B
| $8.89M | 0.11% |
+537,104
| New | +$9.98M |
|
Similar funds
Joel Greenblatt's Q2 2016 Portfolio in Review
As of Q2 2016, Joel Greenblatt held 1,194 positions worth $8.34B, down 6.5% from $8.92B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Joel Greenblatt withdrew a net $527M in Q2 2016, closing 260 positions and reducing 357 holdings. Its most notable exit was Viatris, an estimated $38.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Twenty-First Century Fox, Inc. Class A worth $76.3M.
- Joel Greenblatt's largest Q2 2016 buy was Twenty-First Century Fox, Inc. Class A: 2,822,168 shares worth $76.3M.
- Joel Greenblatt added most to Paramount Global Class B in Q2 2016, an estimated $51.9M increase.
- Joel Greenblatt's biggest Q2 2016 reduction was Texas Instruments, cutting an estimated $40.5M.
- Joel Greenblatt fully exited Viatris in Q2 2016, selling an estimated $38.8M.
- Joel Greenblatt's ten largest holdings make up 9% of its $8.34B portfolio in Q2 2016.
- Joel Greenblatt opened 244 new positions and closed 260 in Q2 2016.
- Joel Greenblatt's portfolio value fell 6.5% quarter-over-quarter to $8.34B.
Based on Gotham Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.